Emission spectra (top) and normalized emission spectra (middle) of Spark PLUS UV™ 395 run on a 5-laser Cytek™ Aurora Spectral Cytometer. To compare Spark PLUS UV™ 395 with other fluorophores on a spectral cytometer, use our Aurora Spectral Analyzer tool.
Normalized excitation and emission spectra (bottom) of Spark PLUS UV™ 395 obtained from a spectrophotometer. To compare Spark PLUS UV™ 395 with other fluorophores, use our Fluorescence Spectra Analyzer tool.
Human peripheral blood lymphocytes were stained with anti-human CD3 APC and anti-human CD4 (clone SK3) Spark PLUS UV 395 (left) or anti-human CD4 (clone SK3) BD Horizon™ BUV395 (right). Samples were acquired on a 5-laser Cytek® Aurora.
Panel A demonstrates how Spark PLUS UV™ 395 performs in a multicolor panel with fluorophores that may exhibit spectral overlap with it. Panel B is shown as a reference panel using pre-optimized fluorophores to ensure that staining patterns are similar.
Marker |
Panel A Fluorophore |
Panel B Fluorophore |
---|---|---|
CD3 |
Spark Violet™ 538 |
FITC |
CD4 |
Spark PLUS UV™ 395 |
Spark PLUS UV™ 395 |
CD8 |
FITC |
APC |
CD19 |
Brilliant Violet 570™ |
PE |
CD25 |
Brilliant Violet 421™ |
Brilliant Violet 421™ |
Human PBMCs were stained with the indicated antibodies and analyzed on a conventional flow cytometer. All plots are gated on lymphocytes.
Human PBMCs were stained with anti-human CD8 Spark UV 387 and anti-human CD4 (clone SK3) Spark PLUS UV 395 (left) or anti-human CD4 (clone SK3) APC (right). Samples were acquired on a 5-laser Cytek® Aurora cytometer.
All BioLegend fluorophores undergo rigorous testing procedures to determine how light, heat, and fixation may affect the performance and ensure they will perform reliably. To compare the signal across different conditions and timepoints, we used the Stain Index (formula below) to measure the relative brightness of the antibody.
Photostability Testing
The photostability of Spark PLUS UV™ 395 was tested in two ways that mimic how an antibody may be exposed to light over the course of an experiment.
To assess the photostability of Spark PLUS UV™ 395-conjugated antibodies, anti-human CD4 (clone SK3) Spark PLUS UV™ 395 or BD Horizon™ BUV395 conjugates were exposed to light or protected in the dark (left). The samples were then used to stain human PBMCs and the fold change over the staining index at zero hours was calculated. To measure the photostability of Spark PLUS UV™ 395 stained cells, human PBMCs were stained with anti-human CD4 (clone SK3) Spark PLUS UV™ 395 or BD Horizon™ BUV395. The fold change in staining index of stained cells kept in the dark or exposed to light was calculated from the initial staining index at zero hours (right). Cells were gated on lymphocytes and data was acquired on a 5-laser Cytek® Aurora.
Heat Stability
Anti-human CD4 (clone SK3) Spark PLUS UV™ 395 was aliquoted and incubated at the indicated temperatures over the course of 28 days, and then analyzed on a 5-laser Cytek™ Aurora cytometer. The antibodies were then used to stain human lysed whole blood from a single donor.
Fixative Stability
A guide to the fixatives used in this experiment:
Human PBMCs were stained with anti-human CD4 (clone SK3) conjugated to Spark PLUS UV™ 395 and fixed using the respective protocols for each buffer set. Fresh samples were fixed and read on a 5-laser Cytek™ Aurora Cytometer immediately. Overnight samples were fixed and stored in Cyto-Last™ Buffer overnight before reading.